Clinical Trial to Evaluate MDW for Early Detection of Sepsis - Trial NCT06267742
Access comprehensive clinical trial information for NCT06267742 through Pure Global AI's free database. This phase not specified trial is sponsored by Beckman Coulter, Inc. and is currently Recruiting. The study focuses on Sepsis. Target enrollment is 2200 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Beckman Coulter, Inc.
Timeline & Enrollment
N/A
Jun 23, 2022
Sep 30, 2024
Primary Outcome
sensitivity, specificity
Summary
This study is intended to clinically verify Monocyte Distribution Width (MDW) parameter of
 DxH 900 Hematology Analyzer for use in early detection and risk assessment of sepsis, severe
 sepsis, and septic shock in critically ill patients in Emergency Department (ED). This study
 is also aimed to provide study supporting data for the product to be marketed in China.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06267742
Non-Device Trial